8 terminated. 8 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
| Phase 3 | 1 | Terminated 1 |
Follow Fibromyalgia: new trials by email Literature Review of Fibromyalgia trials Research Report on Fibromyalgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iTBS-DCS in Fibromyalgia D-Cycloserine, Placebo oral tablet, iTBS repetitive Transcranial Magnetic Stimulation (rTMS) - Fibromyalgia | Phase 2 | Terminated | University of Calgary | 47 | 2022-08-29 | 2025-08-17 |
| A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia Fremanezumab, Placebo - Fibromyalgia | Phase 2 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 189 | 2019-07-31 | 2023-03-30 |
| Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia Milnacipran, Placebo - Primary Fibromyalgia | Phase 2 | Terminated | Forest Laboratories | 116 | 2011-04-30 | 2019-05-14 |
| Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia Milnacipran - Primary Fibromyalgia | Phase 2 | Terminated | Forest Laboratories | 57 | 2011-04-01 | 2013-09-30 |
| Pramipexole ER vs. Placebo in Fibromyalgia pramipexole ER, placebo - Fibromyalgia | Phase 2 | Terminated | Boehringer Ingelheim | 61 | 2008-07-01 | 2014-06-09 |
| A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia Desvenlafaxine Sustained Release (DVS SR), Lyrica® (Pregabalin), Placebo - Fibromyalgia | Phase 2 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 125 | 2008-06-01 | 2013-02-25 |
| Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome placebo, AGN 203818 - Fibromyalgia | Phase 2 | Terminated | Allergan | 211 | 2007-03-01 | 2015-09-07 |
| Study Evaluating the Efficacy of DVS-233 in Fibromyalgia DVS-233 - Fibromyalgia | Phase 2 / Phase 3 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 1050 | 2006-08-01 | 2007-12-05 |
Muscular Diseases (8) · Musculoskeletal Diseases (8) · Nervous System Diseases (8) · Neuromuscular Diseases (8) · Rheumatic Diseases (8) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
Milnacipran (2) · Cycloserine (1) · Pregabalin (1) · fremanezumab (1)
Forest Laboratories (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · Allergan (1) · Boehringer Ingelheim (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · University of Calgary (1)
United States (7) · Canada (1) · Switzerland (1) · United Kingdom (1)
Patricia M D'Astoli, LPN (2) · Alexander McGirr, MD, PhD (1)